Paul F. Truex, Director at Trius Therapeutics Inc (TSRX), bought 8,364 shares at $3.50 ($13K) on 2010-11-23, disclosed to the SEC on 2010-11-24.
Open-market purchase of $13k TSRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.29 | 7,364 | $9K | 73.1% |
| 2 | $3.50 | 1,000 | $4K | 26.9% |
| Total | $1.55 avg | 8,364 | $13K | 100% |
| Filing → |
| ANTH | BUY | 2012-07-02 | $15K | — | Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |